Management of a Hospital Transfusion Service During a Nationwide Blood Product Shortage

To the Editor.-On June 21, 2016, our blood supplier informed the Beth Israel Deaconess Medical Center (Boston, Massachusetts) blood bank (and all customers) about a blood product shortage affecting blood centers nationwide. With the assistance of members of the Beth Israel Deaconess Medical Center q...

Full description

Saved in:
Bibliographic Details
Published inArchives of pathology & laboratory medicine (1976) Vol. 142; no. 7; pp. 779 - 781
Main Authors O'Brien, Kerry L, Mohammed, Monique, Uhl, Lynne
Format Journal Article
LanguageEnglish
Published United States College of American Pathologists 01.07.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To the Editor.-On June 21, 2016, our blood supplier informed the Beth Israel Deaconess Medical Center (Boston, Massachusetts) blood bank (and all customers) about a blood product shortage affecting blood centers nationwide. With the assistance of members of the Beth Israel Deaconess Medical Center quality services division and the transfusion committee, the transfusion service created a blood shortage management algorithm (Figure) and delineated membership of the BSTF (Table). The decision by the transfusion service medical director to trigger the BSTF takes into account (1) whether the product is essential for patient care, (2) if long-term depletion is truly forecast, (3) if multiple services and multiple users are predicted to be affected, (4) if there is no therapeutic alternative (eg, fibrinogen concentrate could be considered a therapeutic alternative to cryoprecipitate; we do not routinely stock fibrinogen concentrate, but have the ability to bring it into inventory if required), and (5) if there is a marked transfusion medicine concern for patient safety. Kerry L. O'Brien, MD; Monique Mohammed, MS(ASCP), SBB; Lynne Uhl, MD Blood Bank, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts Blood Shortage Task Force Membership Medical director of transfusion medicine Senior vice president for health care quality Director of regulatory affairs Hospital legal representative Physician staff representative Senior vice president for ambulatory practice Senior vice president for inpatient services Ethics staff representative Social work representative Referral management representative Pharmacy representative Corporate affairs/communications representative Accepted for publication January 30, 2018.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0003-9985
1543-2165
1543-2165
DOI:10.5858/arpa.2017-0483-LE